CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript March 26, 2025
CollPlant Biotechnologies Ltd. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.42.
Operator: Welcome to the CollPlant Biotechnologies Ltd. Investor Conference Call to discuss financial results for the full year and fourth quarter of 2024 and corporate updates. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal...
